Inventor
Ding-Quan Qian
Inventor
Newark, DE, US
Overview
Patents· 34 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds34%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
A61KPreparations for medical, dental or toiletry purposes28%
C12NMicroorganisms or enzymes2%
C12YEnzymes2%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
Y02ATechnologies for adaptation to climate change1%
PatentTitleYear
11,014,923Bicyclic heterocycles as FGFR4 inhibitors202111,001,571Bipyrazole derivatives as JAK inhibitors202110,947,230Bicyclic heterocycles as FGFR inhibitors202110,851,105Bicyclic heterocycles as FGFR4 inhibitors202010,806,785Immunomodulator compounds and methods of use202010,800,768Heterocyclic compounds as immunomodulators202010,738,052Imidazotriaines and imidazopyrimidines as kinase inhibitors202010,738,048Bicyclic heterocycles as FGFR4 inhibitors202010,513,493Cyclopropylamines as LSD1 inhibitors201910,435,392Bipyrazole derivatives as JAK inhibitors201910,214,528Bicyclic heterocycles as FGFR4 inhibitors20199,957,229Amido compounds and their use as pharmaceuticals20189,944,645Imidazotriazines and imidazopyrimidines as kinase inhibitors20189,890,156'Bicyclic heterocycles as FGFR4 inhibitors'20189,670,154'Amido compounds and their use as pharmaceuticals'20179,533,984'Bicyclic heterocycles as FGFR inhibitors'20179,527,835'Cyclopropylamines as LSD1 inhibitors'20169,493,450'Cyclopropylamines as LSD1 inhibitors'20169,382,231'Bipyrazole derivatives as JAK inhibitors'20169,266,892'Fused pyrazoles as FGFR inhibitors'20169,126,927'Amido compounds and their use as pharmaceuticals'20158,563,570'Lactam compounds and their use as pharmaceuticals'20138,481,732'Substituted heterocyclic compounds'20138,461,330'Imidazotriazines and imidazopyrimidines as kinase inhibitors'20138,436,008'Substituted heterocyclic compounds'20138,193,207'Lactam compounds and methods of using the same'20128,143,251'Triazolotriazines as kinase inhibitors'20128,110,581'Lactam compounds and their use as pharmaceuticals'20128,058,288'Amido compounds and their use as pharmaceuticals'20117,915,408'Triazolotriazines as kinase inhibitors'20117,776,874'Amido compounds and their use as pharmaceuticals'20107,767,675'Imidazotriazines and imidazopyrimidines as kinase inhibitors'20107,683,060'Triazolotriazines as kinase inhibitors'20107,304,081'Amido compounds and their use as pharmaceuticals'2007Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2007–2021Patents assigned to INCYTE CORP (34)· patent assignee history
2007–2021Based in Newark, DE, US· patent location history
2011–2015Patents assigned to QIAN DING-QUAN (9)· patent assignee history
2011–2015Patents assigned to YAO WENQING (9)· patent assignee history
2011–2015Patents assigned to ZHUO JINCONG (9)· patent assignee history
2015–2021Patents assigned to INCYTE HOLDINGS CORP (8)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| INCYTE CORP | 34 | 2007–2021 |
| QIAN DING-QUANself | 9 | 2011–2015 |
| YAO WENQING | 9 | 2011–2015 |
| ZHUO JINCONG | 9 | 2011–2015 |
| INCYTE HOLDINGS CORP | 8 | 2015–2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| Newark, Delaware, US | 34 | 2007–2021 |